1. Home
  2. EVO vs EFC Comparison

EVO vs EFC Comparison

Compare EVO & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • EFC
  • Stock Information
  • Founded
  • EVO 1993
  • EFC 2007
  • Country
  • EVO Germany
  • EFC United States
  • Employees
  • EVO N/A
  • EFC N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • EFC Real Estate
  • Sector
  • EVO Health Care
  • EFC Finance
  • Exchange
  • EVO Nasdaq
  • EFC Nasdaq
  • Market Cap
  • EVO 1.4B
  • EFC 1.3B
  • IPO Year
  • EVO 2021
  • EFC 2010
  • Fundamental
  • Price
  • EVO $4.15
  • EFC $13.29
  • Analyst Decision
  • EVO Strong Buy
  • EFC Strong Buy
  • Analyst Count
  • EVO 1
  • EFC 7
  • Target Price
  • EVO $7.00
  • EFC $14.46
  • AVG Volume (30 Days)
  • EVO 42.9K
  • EFC 1.1M
  • Earning Date
  • EVO 11-05-2025
  • EFC 11-05-2025
  • Dividend Yield
  • EVO N/A
  • EFC 11.72%
  • EPS Growth
  • EVO N/A
  • EFC N/A
  • EPS
  • EVO N/A
  • EFC 1.24
  • Revenue
  • EVO $912,894,891.00
  • EFC $312,485,000.00
  • Revenue This Year
  • EVO N/A
  • EFC N/A
  • Revenue Next Year
  • EVO $10.78
  • EFC $11.48
  • P/E Ratio
  • EVO N/A
  • EFC $10.75
  • Revenue Growth
  • EVO N/A
  • EFC 10.76
  • 52 Week Low
  • EVO $2.84
  • EFC $11.12
  • 52 Week High
  • EVO $5.64
  • EFC $14.40
  • Technical
  • Relative Strength Index (RSI)
  • EVO 63.61
  • EFC 43.34
  • Support Level
  • EVO $4.05
  • EFC $13.24
  • Resistance Level
  • EVO $4.27
  • EFC $13.51
  • Average True Range (ATR)
  • EVO 0.09
  • EFC 0.21
  • MACD
  • EVO 0.01
  • EFC -0.04
  • Stochastic Oscillator
  • EVO 73.91
  • EFC 21.72

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: